SCHEMBL6846574

SCHEMBL6846574

CC[Si](CC)(CC)OC1(CCO)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852084 0.98
SCHEMBL6850330 0.98
SCHEMBL6850307 0.83
SCHEMBL6846572 0.82
SCHEMBL6850384 0.82
SCHEMBL20365508 0.70 CYP4F2 (0.36)
SCHEMBL11127725 0.69 CYP4F2 (0.31)
SCHEMBL11233349 0.69 CYP4F2 (0.31)
SCHEMBL11238651 0.69 CYP4F2 (0.31)
SCHEMBL23781888 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0805682-B1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2004-08-11 EP disclosed
US-5827883-A TOPICAL DRUG DELIVERY; SIDE EFFECT REDUCTION HOFFMANN-LA ROCHE INC. (US) 1998-10-27 US disclosed
EP-0805682-A1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-12 EP disclosed
WO-1996022776-A1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1996-08-01 WO disclosed